Using positron emission tomography (PET) response criteria in solid tumours (PERCIST) 1.0 for evaluation of 2′‐deoxy‐2′‐[18 F] fluoro‐D‐glucose‐PET/CT scans …

J Fledelius, AA Khalil, K Hjorthaug… - Journal of Medical …, 2016 - Wiley Online Library
Introduction The demand for early‐response evaluation with 2′‐deoxy‐2′‐[18 F] fluoro‐D‐
glucose (F‐18‐FDG) positron emission tomography combined with whole body CT (PET/CT) …

[HTML][HTML] The role of positron emission tomography in the management of non–small cell lung cancer

A Behzadi, Y Ung, V Lowe… - Canadian Journal of …, 2009 - ncbi.nlm.nih.gov
The potential use of positron emission tomography (PET) imaging in patients with non–small
cell lung cancer (NSCLC) is broadly divided into 5 categories: management of solitary …

[HTML][HTML] Use of Positron Emission Tomography/Computed Tomography in radiation treatment planning for lung cancer

K Berberoğlu - Molecular imaging and radionuclide therapy, 2016 - ncbi.nlm.nih.gov
Radiotherapy (RT) plays an important role in the treatment of lung cancer. Accurate
diagnosis and staging are crucial in the delivery of RT with curative intent. Target miss can …

The impact of positron emission tomography on clinical decision making in a university-based multidisciplinary lung cancer practice

S Sachs, TV Bilfinger - Chest, 2005 - Elsevier
Introduction Positron emission tomography (PET) scanning has gained increasing
application as a diagnostic and staging tool in the evaluation of lung cancer. Although PET …

Interobserver and intraobserver variability among measurements of FDG PET/CT parameters in pulmonary tumors

G Büyükdereli, M Güler, G Şeydaoğlu - Balkan medical journal, 2016 - dergipark.org.tr
Background: 18F-fluorodeoxyglucose (FDG) positron emission tomography computed
tomography (PET/CT) provides information about metabolic and morphologic status of …

Image-derived biomarkers and multimodal imaging strategies for lung cancer management

AW Sauter, N Schwenzer, MR Divine, BJ Pichler… - European Journal of …, 2015 - Springer
Non-small-cell lung cancer is the most common type of lung cancer and one of the leading
causes of cancer-related death worldwide. For this reason, advances in diagnosis and …

The value of positron emission tomography in patients with non-small cell lung cancer

F Kee, S Erridge, I Bradbury, K Cairns - European journal of radiology, 2010 - Elsevier
BACKGROUND: Pre-operative assessment of non-small cell lung cancer (NSCLC) is a
major application of positron emission tomography (FDG-PET). Despite substantial evidence …

Cost-effectiveness analysis in the clinical management of patients with known or suspected lung cancer:[^ sup 18^ F] fluorodeoxyglucose PET and CT comparison

M Mansueto, A Grimaldi, A Torbica… - … Quarterly Journal of …, 2007 - search.proquest.com
AIM: The aim of this study was to evaluate the economic impact of the introduction of
positron emission tomography (PET) in the clinical management of patients with known or …

Evaluation of semiquantitative assessments of fluorodeoxyglucose uptake on positron emission tomography scans for the diagnosis of pulmonary malignancies 1 to 3 …

Y Ohba, H Nomori, H Shibata, H Kobayashi… - The Annals of thoracic …, 2009 - Elsevier
BACKGROUND: To determine the optimal method of evaluating fluorodeoxyglucose (FDG)
uptake on positron emission tomography (PET) for the diagnosis of pulmonary …

2-Deoxy-2-[18F] fluoro-D-glucose positron emission tomography in target volume definition for radiotherapy of patients with non-small-cell lung cancer

U Nestle, D Hellwig, S Schmidt, N Licht, K Walter… - Molecular Imaging & …, 2002 - Elsevier
Purpose: To discuss the potential contribution of 2-deoxy-2-[18F] fluoro-D-glucose positron
emission tomography (FDG-PET) in radiotherapy planning for non-small-cell lung cancer …